AzTrials
AzTrials

Hand InjuriesM3DMENCT04895891

3D Personalized Modelization of the Hand Using EOS Imaging System

A study testing EOS hand imaging in people with Hand Injuries, run by Centre Hospitalier Universitaire de Besancon at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to compare the quality of 3D hand modelization with EOS imaging with gold-standard computed tomography Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hand Injuries
What is being tested?
EOS hand imaging
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteFrance
Study dates
6 Oct 2020to Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient with hand/wrist CT required
  • Informed consent form signed

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

François Loisel, MD contact

0033381667540

floisel@chu-besancon.fr

France1 site, 1 recruiting
  • CHU de Besançon

    Besançon

    François Loisel, MD

    François Loisel, MS

    Recruiting

Other trials in France

About this study

This study aims to compare the quality of 3D hand modelization with EOS imaging with gold-standard computed tomography

Conditions
Hand Injuries
Being tested
EOS hand imaging
Medical subject headings
Hand Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EOS hand imagingDevice

    For each patient, EOS images are compared with CT images

Study groups in NCT04895891
Study groupRoleWhat they receive
EOS imagingExperimentalFor each patient, EOS images are compared with computed tomography [CT] images
Receives: Device: EOS hand imaging

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Data obtained through EOS imaging

    Precision and correlation of the 3D modelization of hand is compared between the two imaging methods

    Measured: Day 60

  2. Data obtained through standard CT

    Precision and correlation of the 3D modelization of hand is compared between the two imaging methods

    Measured: Day 60

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2021
  2. Study start6 Oct 2020
  3. Primary completionDec 2025 (estimated)
  4. Study completionDec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04895891
Sponsor's protocol ID
P/2019/444
Acronym
M3DME
Status last verified
Sep 2024
First submitted
17 May 2021
Last updated
19 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing EOS hand imaging in people with Hand Injuries, run by Centre Hospitalier Universitaire de Besancon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact François Loisel, MD (0033381667540, floisel@chu-besancon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Data obtained through EOS imaging (time frame: Day 60). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in